SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 DiabetesNeurol 103:e209805, Kim,H.K.,et al, 2024
Apoptosis and Caspases in Neurodegenerative DiseasesNEJM 348:1365-1375, Friedlander,R.M., 2003